Korro Bio (KRRO) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Vogenx is the larger company by market cap ($176.3 million vs $167.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRRO | VOGX |
|---|---|---|
| Share price | $12.18 | $11.87 |
| Market cap | $167.18M | $176.33M |
| 1-day change | -0.08% | -7.30% |
| YTD return | +52.06% | — |
| 1-year return | +93.95% | — |
| 5-year return | -95.67% | — |
| EPS (TTM) | $-8.89 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $6.39M | — |
| Revenue growth (YoY) | +181.46% | — |
| Net income (latest FY) | $-117.26M | — |
| Operating margin | -1906.37% | — |
| Net margin | -1834.48% | — |
| 52-week high | $17.35 | $38.41 |
| 52-week low | $5.20 | $11.51 |
| Distance from 52-week high | -29.81% | -69.10% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +76.52% | +363.35% |
| Average volume | 186.03K | 128.78K |
| Shares outstanding | 13.73M | 14.86M |
| Employees | 58 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Korro Bio
KRRO stock →Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
KRRO vs VOGX FAQ
Which is bigger, Korro Bio or Vogenx?
Vogenx (VOGX) is larger, with a market capitalization of $176.33M compared with $167.18M for Korro Bio (KRRO).
Are Korro Bio and Vogenx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.